Trial
NCT04868045
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
—
Condition
Thyroid Cancer
Intervention
Thyrotropin Releasing Hormone (TRH)
Why stopped
Lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-21